Cargando…
Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates
BACKGROUND: National efforts to control US healthcare spending are potentially undermined by changes in patient characteristics, and in particular increases in rates of obesity and overweight. The objective of this study was to provide current estimates of the effect of obesity and overweight on hea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101934/ https://www.ncbi.nlm.nih.gov/pubmed/35562724 http://dx.doi.org/10.1186/s12889-022-13176-y |
_version_ | 1784707208477409280 |
---|---|
author | van den Broek-Altenburg, Eline Atherly, Adam Holladay, Evon |
author_facet | van den Broek-Altenburg, Eline Atherly, Adam Holladay, Evon |
author_sort | van den Broek-Altenburg, Eline |
collection | PubMed |
description | BACKGROUND: National efforts to control US healthcare spending are potentially undermined by changes in patient characteristics, and in particular increases in rates of obesity and overweight. The objective of this study was to provide current estimates of the effect of obesity and overweight on healthcare spending overall, by service line and by payer using the National Institutes of Health classifications for BMI. METHODS: We used a quasi-experimental design and analyzed the data using generalized linear models and two-part models to estimate obesity- and overweight-attributable spending. Data was drawn from the 2006 and 2016 Medical Expenditures Panel Survey. We identified individuals in the different BMI classes based on self-reported height and weight. RESULTS: Total medical costs attributable to obesity rose to $126 billion per year by 2016, although the marginal cost of obesity declined for all obesity classes. The overall spending increase was due to an increase in obesity prevalence and a population shift to higher obesity classes. Obesity related spending between 2006 and 2016 was relatively constant due to decreases in inpatient spending, which were only partially offset by increases in outpatient spending. CONCLUSIONS: While total obesity related spending between 2006 and 2016 was relatively constant, by examining the effect of different obesity classes and overweight, it provides insight into spend for each level of obesity and overweight across service line and payer mix. Obesity class 2 and 3 were the main factors driving spending increases, suggesting that persons over BMI of 35 should be the focus for policies focused on controlling spending, such as prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13176-y. |
format | Online Article Text |
id | pubmed-9101934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91019342022-05-14 Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates van den Broek-Altenburg, Eline Atherly, Adam Holladay, Evon BMC Public Health Research Article BACKGROUND: National efforts to control US healthcare spending are potentially undermined by changes in patient characteristics, and in particular increases in rates of obesity and overweight. The objective of this study was to provide current estimates of the effect of obesity and overweight on healthcare spending overall, by service line and by payer using the National Institutes of Health classifications for BMI. METHODS: We used a quasi-experimental design and analyzed the data using generalized linear models and two-part models to estimate obesity- and overweight-attributable spending. Data was drawn from the 2006 and 2016 Medical Expenditures Panel Survey. We identified individuals in the different BMI classes based on self-reported height and weight. RESULTS: Total medical costs attributable to obesity rose to $126 billion per year by 2016, although the marginal cost of obesity declined for all obesity classes. The overall spending increase was due to an increase in obesity prevalence and a population shift to higher obesity classes. Obesity related spending between 2006 and 2016 was relatively constant due to decreases in inpatient spending, which were only partially offset by increases in outpatient spending. CONCLUSIONS: While total obesity related spending between 2006 and 2016 was relatively constant, by examining the effect of different obesity classes and overweight, it provides insight into spend for each level of obesity and overweight across service line and payer mix. Obesity class 2 and 3 were the main factors driving spending increases, suggesting that persons over BMI of 35 should be the focus for policies focused on controlling spending, such as prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13176-y. BioMed Central 2022-05-13 /pmc/articles/PMC9101934/ /pubmed/35562724 http://dx.doi.org/10.1186/s12889-022-13176-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article van den Broek-Altenburg, Eline Atherly, Adam Holladay, Evon Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title | Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title_full | Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title_fullStr | Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title_full_unstemmed | Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title_short | Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
title_sort | changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101934/ https://www.ncbi.nlm.nih.gov/pubmed/35562724 http://dx.doi.org/10.1186/s12889-022-13176-y |
work_keys_str_mv | AT vandenbroekaltenburgeline changesinhealthcarespendingattributabletoobesityandoverweightpayerandservicespecificestimates AT atherlyadam changesinhealthcarespendingattributabletoobesityandoverweightpayerandservicespecificestimates AT holladayevon changesinhealthcarespendingattributabletoobesityandoverweightpayerandservicespecificestimates |